Key result
Angiotensin II increases renal adenosine content, downregulating A2 receptors and enhancing the constrictive effects of AngII in the renal vasculature.
This review highlights the mechanisms by which adenosine and angiotensin II synergistically regulate renal vascular resistance, primarily through modulation of adenosine receptors.
ADO-AngII interaction mechanisms remain incompletely understood; leaves open precise renal autoregulation targets for mechanistic studies.
PURPOSE OF THE REVIEW: The adenosine-angiotensin II (ADO-AngII) interaction plays an important role in the regulation of glomerular filtration rate, vascular resistance and tubuloglomerular feedback. Although the interaction was described more than 30 years ago, the intrinsic mechanisms of the synergism between both autacoids remains incompletely understood. RECENT FINDINGS: Current evidence suggests that ADO-metabolizing enzymes such as ecto-5'-nucleotidase or ADO deaminase, as well as enzymes that degrade ATP to adenosine, play an important role in the vasoconstrictor signals sent from the macula densa to the afferent arterioles when tubuloglomerular feedback is activated; increased ADO concentration induced by temporal infusion of AngII results in downregulation of A2 ADO receptors, leading to a predominant effect of A1 receptors; the alteration in the ADO receptors balance further contributes to the synergic interaction between ADO and AngII. SUMMARY: The ADO-metabolizing enzymes have become important regulators of the effects of ADO on the tone of the afferent and efferent arterioles. As AngII is able to increase de-novo renal ADO content through decrease of ADO-metabolizing enzymes, accumulation of ADO induces downregulation of ADO A2 receptor population without modifying ADO A1 receptor, thereby enhancing the constrictive effects of AngII in the renal vasculature.
No takes yet. Share an insight, caveat, or question.
Franco et al. (2008) conducted a review in Kidney vascular resistance. Adenosine-angiotensin II interaction was evaluated. Angiotensin II increases renal adenosine content, downregulating A2 receptors and enhancing the constrictive effects of AngII in the renal vasculature.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: